Direct-to-Patient Healthcare Logistics Market Size
| Study Period | 2020 - 2029 |
| Base Year For Estimation | 2023 |
| Market Size (2024) | USD 19.64 Billion |
| Market Size (2029) | USD 28.69 Billion |
| CAGR (2024 - 2029) | 7.89 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Direct-to-Patient Healthcare Logistics Market Analysis
The Direct-to-Patient Healthcare Logistics Market size is estimated at USD 19.64 billion in 2024, and is expected to reach USD 28.69 billion by 2029, growing at a CAGR of greater than 7.89% during the forecast period (2024-2029).
In the fast-evolving healthcare landscape, direct-to-patient (DTP) logistics has emerged as a transformative force, redefining the traditional approaches to healthcare delivery. Yet many organizations need to be aware of the process and its benefits despite their enormous potential for streamlining an effective supply chain that could save millions of human lives.
Several seminars, including medicines training, pharmaceutical equipment, good clinical practice, study design, pharmacovigilance, and interpretation of clinical trials, are made available to employees at no cost.
Clinical trials have always been the main barrier to introducing a new medicinal product. The authors of the World Pharma Today article suggest that testing a single drug costs approximately USD 2.6 billion, with each patient significantly impacting its development cost and length of studies.
In the United States, 40% of people opt out of medical tests/treatment due to a lack of healthcare facilities. In addition, more reasonable access to pharmacies and other medical supply stores for an estimated 100 million Americans must be available.
The direct-to-patient logistics improve the overall patient experience and contribute to better health outcomes. Routine medical visits do not entail the inconvenience of travel or disruption of daily life for patients. Adherence is improved, and patients are empowered to actively participate in their care journey through the convenience of receiving medicines, clinical trial supplies, and healthcare services at their doorstep.
Direct-to-Patient Healthcare Logistics Market Trends
Increase in Prescribed Medicine Delivery Dominating the Market
Chronic diseases and co-morbidities are on the rise alongside the growth of the world's population. The incidence of chronic diseases is expected to increase rapidly, with developing countries accounting for about 60% of the burden. This is a direct consequence of the demand for efficient healthcare delivery systems.
Therefore, easy access to the nearest pharmacy or where you can order deliveries by door is essential. Several delivery systems provide round-the-clock customer care, which helps patients adhere to their treatment plans.
The popularity of delivery services in recent years has primarily been attributed to companies such as Amazon, which pioneered a process called "click and sell." In many sectors, this need for instant satisfaction is spreading, leading to increased demand for services that are available later.
Patients now have access to faster, more convenient care through telemedicine, allowing them to receive care anytime, anywhere. When there is greater customer demand, the need for new or improved technology in different prescription delivery methods increases accordingly.
Starting in 2025, Cleveland Clinic plans to use drones to deliver particular medications to patients' houses. The service will initially send specialty medicines and prescription drugs to patients in their homes from more than a dozen Cleveland Clinic sites throughout Northeast Ohio. In the future, this program will be extended to delivering laboratory samples, prescription meals, surgical supplies, and items for hospital home care services. Most of these shipments would have been dispatched by automotive courier or road transport.
In October 2023, the pharmacy announced Amazon's latest innovation, a drone delivery service for medicines. Initially, the service will be launched in College Station, Texas, where customers can have their prescription drugs delivered outside the door in less than 60 minutes. This new offering is a big feat, evidenced by the company's investment and infrastructure devoted to this effort.
North America is Dominating the Market
An increasing number of clinical trials for drug development conducted by pharmaceutical companies drive the market in this region. As a result of the rise in internet users, increased access to web-based services and online commerce, and the growing use of e-prescriptions by hospitals and other healthcare facilities, the North American market for e-pharmacies is growing substantially. E-prescription is the electronic prescribing technology that allows healthcare professionals to go paperless by sending prescriptions in digital format instead of handwritten prescriptions.
With the ScriptDrop partnership, Uber is expanding its business of delivering prescription drugs. Due to difficulty accessing pharmacies, many patients do not adhere to their prescribed medication regimen. Uber Health's new service allows patient care teams to ship medications directly to patients and track the delivery status to close the loop entirely. More than 3,000 healthcare customers like Boston Medical Center and ModivCare work with Uber Health to provide access to rides to medical appointments.
In March 2022, Walgreens and Labcorp, a global life sciences company, announced the availability of Pixel by Labcorp COVID-19 at-home collection kit, a PCR test available through Labcorp OnDemand, at no cost to individuals who meet clinical guidelines. Walgreens' addition of the kits, provided in collaboration with the US Department of Health and Human Services (HHS), offers convenient and reliable testing services, making it easier for more communities to access them.
In January 2024, pharmaceutical company Eli Lilly and Company launched a program to make its medicines directly available to patients with diabetes, migraine, and obesity. The drug manufacturer based in Indianapolis, Indiana, announced its new LillyDirect digital healthcare experience, which provides online access to independent healthcare providers. Through this, patients can receive prescribed medications via direct home delivery.
Direct-to-Patient Healthcare Logistics Industry Overview
Direct-to-patient healthcare logistics is slightly competitive. The impact of DTP on clinical trials, patient care, and pharmaceutical supply is undeniable as the diseases continue to gain traction. Healthcare service delivery is evolving, focusing on providing patient-centric, effective, and safe care to those who need it. Dropoff, Marken, Access TeleCare, Babylon Health, and Bocsit are among the companies leading this change in healthcare logistics.
Direct-to-Patient Healthcare Logistics Market Leaders
-
Marken
-
Dropoff
-
Access TeleCare
-
Babylon Health
-
Bocsit
*Disclaimer: Major Players sorted in no particular order
Direct-to-Patient Healthcare Logistics Market News
- November 2023: UPS announced that it completed the acquisition of MNX Global Logistics (MNX), a global time-critical logistics provider. The acquisition closed on November 2023, following all required regulatory approvals. The acquisition of MNX expands UPS's time-critical logistics capabilities, especially for the United States, Europe, and Asia healthcare customers.
- June 2023: SkyCell, the innovator and one of the leading manufacturers of temperature-controlled hybrid containers for the pharmaceutical industry partnered with Marken to provide advanced shipping solutions for clinical trials of pharmaceutical products. The collaboration will give Marken SkyCell containers to ship critical and temperature-sensitive drugs.
Direct-to-Patient Healthcare Logistics Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Deliverables
- 1.2 Study Assumptions
- 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS ANS DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Booming Telehealth to Fuel Market
-
4.3 Market Restraints
- 4.3.1 Legal Restrictions
-
4.4 Market Opportunities
- 4.4.1 Advanced Telehealth Technologies
- 4.5 Value Chain / Supply Chain Analysis
-
4.6 Porter's Five Forces Analysis
- 4.6.1 Threat of New Entrants
- 4.6.2 Bargaining Power of Buyers/Consumers
- 4.6.3 Bargaining Power of Suppliers
- 4.6.4 Threat of Substitute Products
- 4.6.5 Intensity of Competitive Rivalry
- 4.7 Impact of COVID-19 on the Market
5. MARKET SEGMENTATION
-
5.1 By Product
- 5.1.1 Prescribed Medicine Delivery
- 5.1.2 Pre-Clinical Supplies
- 5.1.3 Clinical Trial Supplies
- 5.1.4 Home Trial Support
- 5.1.5 Test Samples Collection
-
5.2 By Temperature Type
- 5.2.1 Ambient
- 5.2.2 Chilled/Refrigerated
- 5.2.3 Frozen
- 5.2.4 Cryogenic
-
5.3 By Region
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Russia
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 India
- 5.3.3.2 China
- 5.3.3.3 Japan
- 5.3.3.4 Rest of Asia-Pacific
- 5.3.4 South America
- 5.3.4.1 Brazil
- 5.3.4.2 Argentina
- 5.3.4.3 Rest of South America
- 5.3.5 Middle East and Africa
- 5.3.5.1 United Arab Emirates
- 5.3.5.2 Saudi Arabia
- 5.3.5.3 Rest of Middle East and Africa
6. COMPETITIVE LANDSCAPE
- 6.1 Market Concentration Overview
-
6.2 Company Profiles
- 6.2.1 Marken
- 6.2.2 Clinerion
- 6.2.3 Dropoff
- 6.2.4 Access TeleCare
- 6.2.5 AMD Global Telemedicine
- 6.2.6 Babylon Health
- 6.2.7 Teladoc Health, Inc.
- 6.2.8 Practo Technologies Private Limited
- 6.2.9 Bocsit
- 6.2.10 Avera eCARE
- 6.2.11 Axs Healthcare
- 6.2.12 Hims & Hers Health Inc.*
- *List Not Exhaustive
- 6.3 Other Companies
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
8. APPENDIX
** Subject To AvailablityDirect-to-Patient Healthcare Logistics Industry Segmentation
Direct-to-patient healthcare logistics is a strategy that brings medications, medical supplies, and clinical trial necessities directly to patients' homes. This approach ensures accessibility and convenience, revolutionizing the pharmaceutical industry and the nature of patient care.
A complete background analysis of the direct-to-patient healthcare logistics market, which includes an assessment of the sector and the contribution of the industry to the economy, market overview, market size estimation for critical segments, key regions, and emerging trends in the market segments, market dynamics, and essential production and consumption statistics are covered in the report.
The direct-to-patient healthcare logistics market is segmented by product (prescribed medicine delivery, pre-clinical supplies, clinical trial supplies, home trial support, and test samples collection), temperature type (ambient, chilled/refrigerated, frozen, cryogenic), and region (North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America). The report offers market size and forecasts for the direct-to-patient healthcare logistics market in value (USD) for all the above segments.
| By Product | Prescribed Medicine Delivery | |
| Pre-Clinical Supplies | ||
| Clinical Trial Supplies | ||
| Home Trial Support | ||
| Test Samples Collection | ||
| By Temperature Type | Ambient | |
| Chilled/Refrigerated | ||
| Frozen | ||
| Cryogenic | ||
| By Region | North America | United States |
| Canada | ||
| Mexico | ||
| By Region | Europe | Germany |
| United Kingdom | ||
| France | ||
| Russia | ||
| Spain | ||
| Rest of Europe | ||
| By Region | Asia-Pacific | India |
| China | ||
| Japan | ||
| Rest of Asia-Pacific | ||
| By Region | South America | Brazil |
| Argentina | ||
| Rest of South America | ||
| By Region | Middle East and Africa | United Arab Emirates |
| Saudi Arabia | ||
| Rest of Middle East and Africa |
Direct-to-Patient Healthcare Logistics Market Research FAQs
How big is the Direct-to-Patient Healthcare Logistics Market?
The Direct-to-Patient Healthcare Logistics Market size is expected to reach USD 19.64 billion in 2024 and grow at a CAGR of greater than 7.89% to reach USD 28.69 billion by 2029.
What is the current Direct-to-Patient Healthcare Logistics Market size?
In 2024, the Direct-to-Patient Healthcare Logistics Market size is expected to reach USD 19.64 billion.
Who are the key players in Direct-to-Patient Healthcare Logistics Market?
Marken, Dropoff, Access TeleCare, Babylon Health and Bocsit are the major companies operating in the Direct-to-Patient Healthcare Logistics Market.
What years does this Direct-to-Patient Healthcare Logistics Market cover, and what was the market size in 2023?
In 2023, the Direct-to-Patient Healthcare Logistics Market size was estimated at USD 18.09 billion. The report covers the Direct-to-Patient Healthcare Logistics Market historical market size for years: 2020, 2021, 2022 and 2023. The report also forecasts the Direct-to-Patient Healthcare Logistics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Direct-to-Patient Healthcare Logistics Industry Report
Statistics for the 2024 Direct-to-Patient Healthcare Logistics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Direct-to-Patient Healthcare Logistics analysis includes a market forecast outlook for 2024 to (2024to2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
